Jazz Pharma. v. Avadel CNS Pharma: Federal Circuit Applies a Fact-Specific Approach to the Patent Infringement Safe Harbor (JSON)

lexblog.com/lib/X90ARTM8view recordjson

{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "Jazz Pharma. v. Avadel CNS Pharma: Federal Circuit Applies a Fact-Specific Approach to the Patent Infringement Safe Harbor",
    "url": "https://www.lexblog.com/2025/05/12/jazz-pharma-v-avadel-cns-pharma-federal-circuit-applies-a-fact-specific-approach-to-the-patent-infringement-safe-harbor/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-X90ARTM8",
        "url": "https://www.lexblog.com/lib/X90ARTM8/"
    },
    "datePublished": "2025-05-12T16:33:33-04:00",
    "dateModified": "2025-05-12T13:34:20-04:00",
    "author": {
        "@type": "Person",
        "name": "Gregory DeLassus, Jennifer P. Nock"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Rothwell Figg"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Biosimilars Law Bulletin",
    "about": "Intellectual Property",
    "sourceUrl": "https://www.biosimilarsip.com/?p=5788",
    "sourceStability": "may-move"
}